According to new research (Law, et. All, Nature, 2024), it may be that T lymphocytes appear to play a more important role than we thought in causing active lupus. They […]
Recent lupus research has received significant coverage bringing encouraging results. The research was partially funded by the Lupus Research Alliance (LRA) – an organization the LSI [...]
By Dr. Robert Katz, LSI Board Chair and LSI Medical Advisory Board Chair (CAR T-cell therapy, typically used in cancer treatment, is a form of immunotherapy.In CAR T-cell therapy, blood […]
The lupus community has been fortunate to benefit from new drugs and treatments that have made a huge impact on the quality of life and longevity of patients. How did […]
In those who become infected with COVID-19, treatments are now available. All treatments are more effective if given as soon as possible after a positive COVID-19 test.
Viruses constantly change through mutation and sometimes these mutations result in a new variant of the virus. Some variants emerge and disappear while others persist.
By Dr. Robert Katz Medical Advisory Board The effects of exercise intervention on health-related quality of life in patients with systemic lupus in the journal Healthcare. In this study, 1,058 [...]
By Dr. Robert Katz Medical Advisory Board Pharmacies are now offering booster shots for immunocompromised patients. Many lupus patients qualify because they are being treated with prednisone and [...]
By Dr. Robert Katz According to the CDC, the Delta variant of COVID-19 is more contagious – more than 2x as contagious as previous variants; some data suggest the Delta […]